BIOCRYST PHARMACEUTICALS, INC.: cashflow_financing

Value{"amount": 5077000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2023-01-01 – 2023-03-31
Statuscurrent
EntityBIOCRYST PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001628280-23-016458
Retrieved: 2026-08-19T08:48:50.529413+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000882796/cashflow-financing/2023-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/6675492c-ec39-4b14-9cb1-85d99c54af2b

History